Maine Medical Center's Institutional Review Board (MMC IRB) is a standing committee responsible for protecting the rights and welfare of people who are subjects in research activities. The MMC HRPP program and policies sets forth the IRB's basic operational procedures.
All research projects involving human subjects, regardless of the source of funding, require review and approval by an IRB prior to implementation. It is the role of the MMC IRB or its designee to determine if research activity requires review, including those activities that may meet exemption criteria.
Maine Medical Center IRB has contracted with Chesapeake IRB to be our IRB of Record for FDA industry sponsored studies. Researchers conducting FDA industry sponsored studies will be required to complete an MMC external IRB form and application with Chesapeake IRB.
In accordance with federal regulations 45 CFR 46 and 21 CFR 50 and 56, the IRB has the authority to approve, require modifications to, disapprove, terminate or suspend research at participating organizations. The purpose of the IRB is to assure, both in advance and by periodic review that appropriate steps are taken to protect the rights and welfare of humans participating as subjects in research.
Administrative support for the IRB is within the Office of Research Compliance at Maine Medical Center Research Institute in Scarborough Maine.
The IRB meets once a month, most always on the last Tuesday of every month.